Prosecution Insights
Prosecution Insights
7 pending office actions • 6 art units • 7 examiners • 0 of 7 (0%) have an AI response strategy ready • 16 patents granted in the last 365 days
Based on the USPTO statutory response window for each pending office action. 7 of the docket's apps have a known mailing date; the rest are excluded from the tile counts.
Every pending office action with a known statutory deadline, placed on a days-until-due axis. Dots left of Today are overdue; the further right, the more runway. Cases that share a deadline window stack vertically. 7 of the docket's apps have a known mailing date.
Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.
| Bucket | Cases |
|---|---|
| §103 only | 6 (86%) |
| No statute on record | 1 (14%) |
How the docket's pending cases split across USPTO tech-center bands.
Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.
| Examiner | Apps on this docket | Allow rate | Interview lift |
|---|---|---|---|
| DONOHUE, SEAN R | 1 | 41.5% | +21.7% |
| GU, QINHUA | 1 | 75.0% | +30.4% |
| CERMAK, ADAM JASON | 1 | 71.3% | +4.7% |
| NICOL, ALEXANDER W | 1 | 42.0% | +44.9% |
| XIAO, YAN | 1 | 67.9% | +51.5% |
| HUSSAINI, ATTIYA SAYYADA | 1 | 57.1% | +14.5% |
| SMALE, AVERY E | 1 | 72.9% | +22.2% |
Cases in front of an examiner whose interview lift is 10 percentage points or more — i.e. interviewed cases historically resolve more favorably than non-interviewed ones. The top 6 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 18603721 | COMPOUNDS AND COMPOSITIONS USEFUL AS RADIOTRACERS FOR IMAGING OF REACTIVE OXIDATIVE SPECIES | DONOHUE, SEAN R | 28d overdue |
| 17048879 | A MEDICAL DEVICE FOR DEPLOYING A CATHETER THAT CAN BE OPERATED WITH A SINGLE HAND, AND A METHOD | SMALE, AVERY E | 24d overdue |
| 18276812 | ENGINEERED EXTRACELLULAR VESICLES AND THEIR USES | NICOL, ALEXANDER W | 9d |
| 18316672 | EPHA3 AND MULTI-VALENT TARGETING OF TUMORS | XIAO, YAN | 21d |
| 17989669 | COMBINED NITRITE AND LIGHT TREATMENT TO PREVENT DEVICE THROMBOSIS | HUSSAINI, ATTIYA SAYYADA | 36d |
| 18289875 | GENE THERAPY FOR DENT DISEASE | GU, QINHUA | 60d |
| Art Unit | Apps |
|---|---|
| 3783 | 2 |
| 1618 | 1 |
| 1633 | 1 |
| 1634 | 1 |
| 1642 | 1 |
| 3792 | 1 |
| App # | Title | Examiner | Art Unit | Statutes | Status | Due in | AI | Filed |
|---|---|---|---|---|---|---|---|---|
| 18603721 | COMPOUNDS AND COMPOSITIONS USEFUL AS RADIOTRACERS FOR IMAGING OF REACTIVE OXIDATIVE SPECIES | DONOHUE, SEAN R | 1618 | §103 | Non-Final OA | 28d overdue | Pending | Mar 13, 2024 |
| 18289875 | GENE THERAPY FOR DENT DISEASE | GU, QINHUA | 1633 | §103 | Non-Final OA | 60d | Pending | Nov 07, 2023 |
| 18454673 | DEVICES, SYSTEMS, AND METHODS FOR AUTONOMOUSLY CONTROLLING A BALLOON CATHETER | CERMAK, ADAM JASON | 3783 | §103 | Non-Final OA | 18d overdue | Pending | Aug 23, 2023 |
| 18276812 | ENGINEERED EXTRACELLULAR VESICLES AND THEIR USES | NICOL, ALEXANDER W | 1634 | §103 | Non-Final OA | 9d | Pending | Aug 10, 2023 |
| 18316672 | EPHA3 AND MULTI-VALENT TARGETING OF TUMORS | XIAO, YAN | 1642 | Other | Non-Final OA | 21d | Pending | May 12, 2023 |
| 17989669 | COMBINED NITRITE AND LIGHT TREATMENT TO PREVENT DEVICE THROMBOSIS | HUSSAINI, ATTIYA SAYYADA | 3792 | §103 | Non-Final OA | 36d | Pending | Nov 17, 2022 |
| 17048879 | A MEDICAL DEVICE FOR DEPLOYING A CATHETER THAT CAN BE OPERATED WITH A SINGLE HAND, AND A METHOD | SMALE, AVERY E | 3783 | §103 | Non-Final OA | 24d overdue | Pending | Oct 19, 2020 |
IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.
Start Free Trial